Compare DDD & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DDD | MLAB |
|---|---|---|
| Founded | 1986 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.0M | 533.0M |
| IPO Year | 2003 | 1995 |
| Metric | DDD | MLAB |
|---|---|---|
| Price | $3.63 | $101.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $4.75 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 3.1M | 146.2K |
| Earning Date | 05-08-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | 109.79 | ★ 436.11 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $386,902,000.00 | N/A |
| Revenue This Year | $2.48 | $6.07 |
| Revenue Next Year | $4.10 | $5.41 |
| P/E Ratio | ★ N/A | $84.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.70 | $59.63 |
| 52 Week High | $4.12 | $113.99 |
| Indicator | DDD | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
3D Systems Corp provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, manufacturing and applications engineering. Its solutions support applications in two key industry verticals: Healthcare Solutions provide surgical planning, implants, instrumentation, and medical education solutions to help medical device manufacturers and healthcare providers accelerate, and ultimately, transform healthcare, and Industrial Solutions which includes aerospace, defense, transportation and general manufacturing. The company operates in the Americas, EMEA, and APAC regions.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.